{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:00:02Z","timestamp":1793350802060,"version":"4.5.0"},"reference-count":33,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Over the years, research regarding the Zika virus has been steadily increasing. Early immunization for ZIKV is a priority for preventing complications such as microencephaly and Guillain\u2013Barr\u00e9 syndrome (GBS). Unlike traditional vaccination approaches, oral dissolving films (ODFs) or mucoadhesive film technology is an emerging, exciting concept that can be used in the field of pharmaceuticals for vaccine design and formulation development. This attractive and novel method can help patients who suffer from dysphagia as a complication of a disease or syndrome. In this study, we investigated a microparticulate Zika vaccine administered via the buccal route with the help of thin films or oral dissolving films (ODFs) with a prime dose and two booster doses two weeks apart. In vitro, the ODFs displayed excellent physiochemical properties, indicating that the films were good carriers for vaccine microparticles and biocompatible with the buccal mucosa. In vivo results revealed robust humoral (IgG, subtypes IgG1 and IgG2a) and T-cell responses (CD4+\/CD8+) for ZIKV-specific immunity. Both the Zika MP vaccine and the adjuvanted Zika MP vaccine affected memory (CD45R\/CD27) and intracellular cytokine (TNF-\u03b1 and IL-6) expression. In this study, ZIKV vaccination via the buccal route with the aid of ODFs demonstrated great promise for the development of pain-free vaccines for infectious diseases.<\/jats:p>","DOI":"10.3390\/vaccines12070720","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T06:51:53Z","timestamp":1719557513000},"page":"720","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Buccal Administration of a Zika Virus Vaccine Utilizing 3D-Printed Oral Dissolving Films in a Mouse Model"],"prefix":"10.3390","volume":"12","author":[{"given":"Sarthak","family":"Shah","sequence":"first","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Patel","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarae","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7151-5018","authenticated-orcid":false,"given":"Priyal","family":"Bagwe","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-3867","authenticated-orcid":false,"given":"Akanksha","family":"Kale","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Adediran","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revanth","family":"Singh","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanisha","family":"Arte","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4780-9658","authenticated-orcid":false,"given":"Dedeepya","family":"Pasupuleti","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Uddin","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Vaccine Nanotechnology Laboratory, Center for Drug Delivery Research, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref_1","unstructured":"Kale, A. (2023). Novel Microparticle-Based Microneedle Vaccine For Zika Virus. [Ph.D. Dissertation, Mercer University]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121975","DOI":"10.1016\/j.ijpharm.2022.121975","article-title":"Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration","volume":"624","author":"Kale","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-018-0061-9","article-title":"Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation","volume":"3","author":"Barrett","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wang, Y., Ling, L., Zhang, Z., and Marin-Lopez, A. (2022). Current Advances in Zika Vaccine Development. Vaccines, 10.","DOI":"10.3390\/vaccines10111816"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41467-017-01923-4","article-title":"Intranasal infection and contact transmission of Zika virus in guinea pigs","volume":"8","author":"Deng","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(16)00651-6","article-title":"Association between Zika virus and microcephaly in French Polynesia, 2013\u20132015: A retrospective study","volume":"387","author":"Cauchemez","year":"2016","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/scd.12435","article-title":"Chronology and sequence of deciduous teeth eruption in children with microcephaly associated to the Zika virus","volume":"40","author":"Chagas","year":"2020","journal-title":"Spec. Care Dent."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/odi.13238","article-title":"Dental changes in children with congenital Zika syndrome","volume":"26","author":"Faria","year":"2020","journal-title":"Oral Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gomes, P.N., do Amaral, B.A., Azevedo, I.D., de Medeiros Maia, H.C., Arrais, N.M.R., and de Lima, K.C. (2022). Association of congenital Zika syndrome with dental alterations in children with microcephaly. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0276931"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jconrel.2014.05.060","article-title":"Buccal and sublingual vaccine delivery","volume":"190","author":"Kraan","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1208\/s12249-016-0566-3","article-title":"Physicochemical and Preclinical Evaluation of a Novel Buccal Measles Vaccine","volume":"18","author":"Gala","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Joshi, D., Shah, S., Chbib, C., and Uddin, M.N. (2024). Potential of DPD ((S)-4,5-dihydroxy-2,3-pentanedione) Analogs in Microparticulate Formulation as Vaccine Adjuvants. Pharmaceuticals, 17.","DOI":"10.3390\/ph17020184"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Lee, J.-H., Park, C., Song, I.-O., Lee, B.-J., Kang, C.-Y., and Park, J.-B. (2022). Investigation of Patient-Centric 3D-Printed Orodispersible Films Containing Amorphous Aripiprazole. Pharmaceuticals, 15.","DOI":"10.3390\/ph15070895"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cupone, I.E., Sansone, A., Marra, F., Giori, A.M., and Jannini, E.A. (2022). Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102011"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2018.01.003","article-title":"Key acceptability attributes of orodispersible films","volume":"125","author":"Scarpa","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"van Meerloo, J., Kaspers, G.J.L., and Cloos, J. (2011). Cell Sensitivity Assays: The MTT Assay, Humana Press.","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-020-00876-4","article-title":"How to select IgG subclasses in developing anti-tumor therapeutic antibodies","volume":"13","author":"Yu","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"De Taeye, S.W., Bentlage, A.E., Mebius, M.M., Meesters, J.I., Lissenberg-Thunnissen, S., Falck, D., S\u00e9nard, T., Salehi, N., Wuhrer, M., and Schuurman, J. (2020). Fc\u03b3R Binding and ADCC Activity of Human IgG Allotypes. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00740"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.biopha.2018.08.027","article-title":"Immunomodulatory effects of hydroxychloroquine on Th1\/Th2 balance in women with repeated implantation failure","volume":"107","author":"Novin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","article-title":"Role of IgG3 in Infectious Diseases","volume":"40","author":"Damelang","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Jones, C.W., Adams, A.C., Murphy, E., King, R.P., Saracco, B., Stesis, K.R., Cavanaugh, S., Roberts, B.W., and Platts-Mills, T.F. (2021). Delays in reporting and publishing trial results during pandemics: Cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials. BMC Med. Res. Methodol., 21.","DOI":"10.1186\/s12874-021-01324-8"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: The results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jan.13818","article-title":"The fear of needles: A systematic review and meta-analysis","volume":"75","author":"McLenon","year":"2019","journal-title":"J. Adv. Nurs."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Shah, S.M., Alsaab, H.O., Rawas-Qalaji, M.M., and Uddin, M.N. (2021). A Review on Current COVID-19 Vaccines and Evaluation of Particulate Vaccine Delivery Systems. Vaccines, 9.","DOI":"10.3390\/vaccines9101086"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Sarthak, S., Dedeepya, D., Emmanuel, A., Amit, B., Devyani, J., Smital, P., Priyal, B., Mohammad, N.U., and Martin, D. (2024). Vaccine adjuvants and carriers. Advanced Vaccination Technologies for Infectious and Chronic Diseases, Elsevier.","DOI":"10.1016\/B978-0-443-18564-9.00022-9"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41580-020-0241-0","article-title":"Mechanisms governing autophagosome biogenesis","volume":"21","author":"Nakatogawa","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jmb.2019.10.028","article-title":"Autophagosome-Lysosome Fusion","volume":"432","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chen, C.H., Chen, C.C., Wang, W.B., Lionel, V., Liu, C.C., Huang, L.M., and Wu, S.C. (2022). Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion Protein Elicits Systemic and Mucosal Immune Responses and Protection against Subcutaneous and Intravaginal Virus Challenges. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14051014"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Vidarsson, G., Dekkers, G., and Rispens, T. (2014). IgG Subclasses and Allotypes: From Structure to Effector Functions. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00520"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T Follicular Helper Cell Differentiation, Function, and Roles in Disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.7150\/ijms.59898","article-title":"The role of NK cells in fighting the virus infection and sepsis","volume":"18","author":"Ma","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108727","DOI":"10.1016\/j.clim.2021.108727","article-title":"Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application","volume":"227","author":"Zuo","year":"2021","journal-title":"Clin. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/7\/720\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:06:51Z","timestamp":1760108811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/7\/720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["vaccines12070720"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12070720","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}